and as a referee for numerous scientific journals and funding agencies, and holds 35 patents on cryopreservation methods, aging interventions, transplantation, and other topics.

As a scientist with the American Red Cross, Fahy was the originator of the first practical method of cryopreservation by vitrification and the inventor of computer-based systems to apply this technology to whole organs.

Naval Medical Research Institute in Bethesda, Maryland where he spearheaded the original concept of ice blocking agents.

The purpose of the TRIIM trial was to investigate the possibility of using recombinant human growth hormone (rhGH) to prevent or reverse signs of immunosenescence in ten 51‐ to 65‐year‐old putatively healthy men.

Fahy also received the Grand Prize for Medicine from INPEX in 1995 for his invention of computerized organ cryoprotectant perfusion technology.